Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
Health
First Opinion
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Adam's Take
STAT+

Taking the measure of small-cap biotech: Bellus Health, OncoSec Medical

  • Adam Feuerstein

By Adam Feuerstein Feb. 8, 2019

Reprints

Welcome back to my semi-regular column tracking the ups and downs in small-cap biotech. Here, I take a look at Bellus Health (BLU) and OncoSec Medical (ONCS). (Read to the end for quick hits on Northwest Biotherapeutics (NWBO) and Ampio Pharmaceuticals (AMPE).)

As a reminder, I’m taking requests for companies to cover, so reach out to me on Twitter (DMs are open), email, or in the comment section of the column.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

What scientists know — and don’t know — about…
What scientists know — and don’t know — about how monkeypox spreads
The campaign to rename monkeypox gets complicated
The campaign to rename monkeypox gets complicated
Another fight for Covid long-haulers: having their pain acknowledged
Another fight for Covid long-haulers: having their pain acknowledged
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: Two children died after getting Novartis gene therapy;…
Pharmalittle: Two children died after getting Novartis gene therapy; monkeypox vaccine maker warns about splitting doses
Wyden wants details on Amgen’s U.S. taxes as part…
Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practices

Comments are closed.

Recommended Stories